Use access key #2 to skip to page content.
$11.70 -0.34 (-2.82%)
8/20/2008 3:30 PM

BioMimetic Therapeutics, Inc. (BMTI)

CAPS Rating:
**

The Company develops and commercializes bio-active drug-device combination products for the healing of musculoskeletal injuries and diseases, including periodontal, orthopedic, spine and sports injury applications.

View All Commentary (BMTI)

Recs

2

Avatar 12bagger (99.90) Submitted: 2/23/07 1:06 PM : Outperform Start Price: $16.74 BMTI Score: -17.74

I like the story here: promising new technology for bone repair, including remedies for periodontal problems. A great healthcare niche in which to market to all of us millions of agers. Admittedly the profits are still out on the horizon, but the future looks very bright.

Report this Post Replies: 1 | Reply

Avatar rzmartin (< 20) Submitted: 6/14/07 4:25 PM

Recs: 0 | Rec This

I bought this a day after the IPO ($6.55) and it has done nothing but grow for my portfolio.

Report this Post Reply

Featured Broker Partners